American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients.
Adam CukerEric K TsengHolger J SchünemannPantep AngchaisuksiriClifton BlairKathryn DaneMaria T DeSanchoDavid DiuguidDaniel O GriffinSusan R KahnFrederikus Albertus KlokAlfred Ian LeeIgnacio NeumannAshok PaiMarc RighiniKristen M SanfilippoDeborah M SiegalMike SkaraDeirdra R TerrellKamshad TouriElie A AklReyad Al JabiriYazan Al JabiriMary Ellene BoulosRomina Brignardello-PetersenRana CharideLuis Enrique Colunga LozanoKarin Lee DearnessAndrea J DarziSamer G KaramGian Paolo MorganoRami Z MorsiBinu A PhilipYetiani Roldan BenitezAdrienne StevensKarla SoloWojtek WierciochReem A MustafaRobby NieuwlaatPublished in: Blood advances (2022)
This conditional recommendation was based on very low certainty in the evidence, underscoring the need for additional, high-quality, randomized controlled trials comparing different intensities of anticoagulation for patients with COVID-19-related critical illness.